产毒艰难梭菌聚合酶链反应检测对临床微生物学实验室和住院患者流行病学的影响。
Impact of toxigenic Clostridium difficile polymerase chain reaction testing on the clinical microbiology laboratory and inpatient epidemiology.
机构信息
Wheaton Franciscan Laboratory, Wauwatosa, WI 53226, USA.
出版信息
Diagn Microbiol Infect Dis. 2013 Aug;76(4):534-8. doi: 10.1016/j.diagmicrobio.2013.04.020. Epub 2013 Jun 2.
Abstract
Conversion from Clostridium difficile toxin A/B EIA to tcdB polymerase chain reaction for diagnosis of C. difficile infection (CDI) resulted in significant decreases in laboratory testing volume and largely unchanged C. difficile toxin detection rates. Decreases in healthcare-associated CDI rates (P ≤ 0.05) reflected a clinical practice benefit of this conversion.
摘要
将艰难梭菌毒素 A/B EIA 转换为 tcdB 聚合酶链反应（PCR）进行艰难梭菌感染（CDI）的诊断，导致实验室检测量显著减少，而艰难梭菌毒素的检测率基本保持不变。与医疗相关的 CDI 发生率的降低（P ≤ 0.05）反映了这种转换的临床实践益处。
Zotero 插件